Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC Greater Than 6 Weeks After Surgery
A Randomized Trial of Accelerated Postoperative Radiotherapy for Intermediate- and High-risk Patients With HNSCC (Head and Neck Squamous Cell Carcinoma) Initiating Radiotherapy Greater Than 6 Weeks After Surgery (PORTRush)
Sponsor: Wake Forest University Health Sciences
Listed as NCT06607406, this NA trial focuses on Head and Neck Cancer and Head and Neck Squamous Cell Carcinoma HNSCC and remains actively recruiting participants. Sponsored by Wake Forest University Health Sciences, it has been updated 5 times since 2025, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
5 versions recorded-
Feb 2026 — Present [monthly]
Recruiting NA
-
Aug 2025 — Feb 2026 [monthly]
Recruiting NA
-
Mar 2025 — Aug 2025 [monthly]
Recruiting NA
-
Jan 2025 — Mar 2025 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2024 — Jan 2025 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Wake Forest University Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .